These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28932159)

  • 21. The list of prohibited substances and methods in sport: structure and review process by the world anti-doping agency.
    Mazzoni I; Barroso O; Rabin O
    J Anal Toxicol; 2011 Nov; 35(9):608-12. PubMed ID: 22080899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultra-fast retroactive processing by MetAlign of liquid chromatography/high-resolution full-scan Orbitrap mass spectrometry data in WADA Human Urine Sample Monitoring Program.
    Khelifi S; Saad K; Vonaparti A; Mahieddine S; Salama S; Saleh A; Al-Mohannadi M; Al-Thaiban H; Lommen A; Horvatovich P; Beotra A; Abushareeda W; Al Maadheed M; Georgakopoulos C
    Rapid Commun Mass Spectrom; 2021 Sep; 35(17):e9141. PubMed ID: 34106497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges and perspectives in anti-doping testing.
    Schamasch P; Rabin O
    Bioanalysis; 2012 Jul; 4(13):1691-701. PubMed ID: 22831484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A; McNamee M
    Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using response-time latencies to measure athletes' doping attitudes: the brief implicit attitude test identifies substance abuse in bodybuilders.
    Brand R; Wolff W; Thieme D
    Subst Abuse Treat Prev Policy; 2014 Sep; 9():36. PubMed ID: 25209168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of anabolic agents including selective androgen receptor modulators in samples outside of sport.
    Bohlin KP; Pohanka A; Andersson A; Villén T; Ekström L
    Drug Test Anal; 2023 Nov; ():. PubMed ID: 37986708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone abuse in sports: the antidoping perspective.
    Barroso O; Mazzoni I; Rabin O
    Asian J Androl; 2008 May; 10(3):391-402. PubMed ID: 18385901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on banned substances 2013.
    Barnes KP; Rainbow CR
    Sports Health; 2013 Sep; 5(5):442-7. PubMed ID: 24427415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis.
    Cadwallader AB; de la Torre X; Tieri A; Botrè F
    Br J Pharmacol; 2010 Sep; 161(1):1-16. PubMed ID: 20718736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2010 Apr; 2(4):149-61. PubMed ID: 20376830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The presence of doping agents in dietary supplements: A glimpse into the Brazilian situation.
    Torres CL; de Oliveira FAG; Jooris LF; Padilha MC; Pereira HMG
    Drug Test Anal; 2024 Jan; 16(1):38-48. PubMed ID: 37161689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of GH abuse in sport: Past, present and future.
    Barroso O; Schamasch P; Rabin O
    Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sports drug testing using complementary matrices: Advantages and limitations.
    Thevis M; Geyer H; Tretzel L; Schänzer W
    J Pharm Biomed Anal; 2016 Oct; 130():220-230. PubMed ID: 27040951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Problems of the use of pseudoephedrine by athletes.
    Pokrywka A; Tszyrsznic W; Kwiatkowska DJ
    Int J Sports Med; 2009 Aug; 30(8):569-72. PubMed ID: 19382058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of doping among Saudi athletes: Results from the National Anti-Doping Program.
    Aljaloud SO; Khoshhal KI; Al-Ghaiheb AA; Konbaz MS; Almasaed AA
    J Taibah Univ Med Sci; 2020 Feb; 15(1):19-24. PubMed ID: 32110178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary Supplement and Food Contaminations and Their Implications for Doping Controls.
    Walpurgis K; Thomas A; Geyer H; Mareck U; Thevis M
    Foods; 2020 Jul; 9(8):. PubMed ID: 32727139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence flow cytometer to determine urine particle reference intervals in doping control samples.
    Robinson N; Sottas PE; Saugy M
    Forensic Sci Int; 2011 Dec; 213(1-3):95-100. PubMed ID: 21889276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of prohibited substances for therapeutic reasons in athletes affected by endocrine diseases and disorders: the therapeutic use exemption (TUE) in clinical endocrinology.
    Di Luigi L; Pigozzi F; Sgrò P; Frati L; Di Gianfrancesco A; Cappa M
    J Endocrinol Invest; 2020 May; 43(5):563-573. PubMed ID: 31734891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analytical strategy for detecting doping agents in hair.
    Thieme D; Grosse J; Sachs H; Mueller RK
    Forensic Sci Int; 2000 Jan; 107(1-3):335-45. PubMed ID: 10689585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2014; 6(1-2):164-84. PubMed ID: 24285613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.